BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16319057)

  • 1. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
    Helton ES; Zhang J; Chen X
    Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
    Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
    Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
    Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
    Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
    Bernassola F; Oberst A; Melino G; Pandolfi PP
    Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
    King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
    Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach.
    Birkaya B; Ortt K; Sinha S
    BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63.
    Romano RA; Birkaya B; Sinha S
    J Invest Dermatol; 2007 May; 127(5):1175-86. PubMed ID: 17159913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
    Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
    Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63.
    Romano RA; Birkaya B; Sinha S
    J Invest Dermatol; 2006 Jul; 126(7):1469-79. PubMed ID: 16645595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activity of the DeltaNp63 promoter is regulated by STAT3.
    Chu WK; Dai PM; Li HL; Chen JK
    J Biol Chem; 2008 Mar; 283(12):7328-37. PubMed ID: 18198175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and DeltaNp63 transcription factors.
    Wang DY; Cheng CC; Kao MH; Hsueh YJ; Ma DH; Chen JK
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3102-8. PubMed ID: 16123408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
    Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
    Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAp63 and DeltaNp63 in cancer and epidermal development.
    Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
    Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itch/AIP4 associates with and promotes p63 protein degradation.
    Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
    Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.